ESR1 and breast cancer: Moreover, c-Jun overexpression abrogated the tamoxifen-mediated growth-inhibitory effects in ER-positive BC cells (Fig. 3e), which suggested that c-Jun contributes to tamoxifen resistance by enhancing FAO activity.